mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for AKR1C3
Gene summary
Basic gene Info.Gene symbolAKR1C3
Gene namealdo-keto reductase family 1, member C3
SynonymsDD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS
CytomapUCSC genome browser: 10p15-p14
Type of geneprotein-coding
RefGenesNM_001253908.1,
NM_001253909.1,NM_003739.5,
Description3-alpha hydroxysteroid dehydrogenase, type II3-alpha-HSD type II, brainaldo-keto reductase family 1 member C3aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)chlordecone reductase homolog HAKRbdihydrodiol dehydro
Modification date20141207
dbXrefs MIM : 603966
HGNC : HGNC
Ensembl : ENSG00000196139
HPRD : 04911
ProteinUniProt: P42330
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_AKR1C3
BioGPS: 8644
PathwayNCI Pathway Interaction Database: AKR1C3
KEGG: AKR1C3
REACTOME: AKR1C3
Pathway Commons: AKR1C3
ContextiHOP: AKR1C3
ligand binding site mutation search in PubMed: AKR1C3
UCL Cancer Institute: AKR1C3
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0000060protein import into nucleus, translocation21787718
GO:0007186G-protein coupled receptor signaling pathway18508192
GO:0008284positive regulation of cell proliferation18508192
GO:0010942positive regulation of cell death21787718
GO:0016488farnesol catabolic process21187079
GO:0034614cellular response to reactive oxygen species21787718
GO:0042448progesterone metabolic process21232532
GO:0042574retinal metabolic process21851338
GO:0048385regulation of retinoic acid receptor signaling pathway21851338
GO:0051897positive regulation of protein kinase B signaling18508192
GO:0055114oxidation-reduction process16983398
GO:0071276cellular response to cadmium ion21787718
GO:0071277cellular response to calcium ion22170488
GO:0071379cellular response to prostaglandin stimulus22170488
GO:0071384cellular response to corticosteroid stimulus19336506
GO:0071395cellular response to jasmonic acid stimulus19487289
GO:0071799cellular response to prostaglandin D stimulus18508192
GO:1900053negative regulation of retinoic acid biosynthetic process21851338
GO:2000353positive regulation of endothelial cell apoptotic process19442656
GO:2000379positive regulation of reactive oxygen species metabolic process19442656


Top
Ligand binding site mutations for AKR1C3

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
K84T82NCOAD1
Y319S320LSKCM1
H117I116FSKCM1
H304H304YSKCM1
Y317P315SSKCM1
L128E126DSTAD1
W227W227LUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for AKR1C3
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
H117I116F-1.3559497
H304H304Y-1.1057686
K84T82N-0.76558605
Y317P315S-0.74446362
L128E126D-0.6654193
W227W227L-0.49132846
Y319S320L-0.455769
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for AKR1C3 from PDB

Top
Differential gene expression and gene-gene network for AKR1C3
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of AKR1C3 and the right PPI network was created from samples without mutations in the LBS of AKR1C3. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for AKR1C3
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0032460Polycystic Ovary Syndrome6Biomarker, GeneticVariation
umls:C0014175Endometriosis2Biomarker
umls:C0028754Obesity2Biomarker
umls:C0033578Prostatic Neoplasms2Biomarker
umls:C0014170Endometrial Neoplasms1AlteredExpression, Biomarker
umls:C0007621Cell Transformation, Neoplastic1Biomarker
umls:C0038356Stomach Neoplasms1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for AKR1C3
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
NutraceuticalDB00157NADHSmall molecule
Approved|investigationalDB00905BimatoprostSmall molecule
Experimental|illicitDB015364-AndrostenedioneSmall molecule
ExperimentalDB01698RutinSmall molecule
ExperimentalDB02056(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-OicacidSmall molecule
ExperimentalDB02266Flufenamic AcidSmall molecule
ExperimentalDB034612'-Monophosphoadenosine 5'-DiphosphoriboseSmall molecule
ExperimentalDB077003-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRANSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of AKR1C3 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NDPNADPH1ry8BH117
ACTACETATE1s1pAH117
NAPNADP ZWITTERION1s1pAH117
ACTACETATE1s1rAH117
NAPNADP ZWITTERION1s1rAH117
NAPNADP ZWITTERION1s2aAH117
NAPNADP ZWITTERION1s2cAH117
NAPNADP ZWITTERION1xf0AH117
NAPNADP ZWITTERION1zq5AH117
NAPNADP ZWITTERION2f38AH117
NAPNADP ZWITTERION2fgbAH117
NAPNADP ZWITTERION3r43AH117
NAPNADP ZWITTERION3r6iAH117
NAPNADP ZWITTERION3r7mAH117
IZPLEVIBUPROFEN3r8gAH117
NAPNADP ZWITTERION3r8hAH117
NAPNADP ZWITTERION3r94AH117
NAPNADP ZWITTERION3ug8AH117
NAPNADP ZWITTERION3ugrAH117
NAPNADP ZWITTERION3uweAH117
NAPNADP ZWITTERION4dbsAH117
NAPNADP ZWITTERION4dbwAH117
NAPNADP ZWITTERION4dbwBH117
NAPNADP ZWITTERION4dz5AH117
NAPNADP ZWITTERION4fa3AH117
NAPNADP ZWITTERION4falAH117
NAPNADP ZWITTERION4famAH117
NAPNADP ZWITTERION4famBH117
NAPNADP ZWITTERION4h7cAH117
NAPNADP ZWITTERION4hmnAH117
NAPNADP ZWITTERION4wrhAH117
YY15-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL4wrhAH117
NAPNADP ZWITTERION4wdtAH117
NAPNADP ZWITTERION4wduAH117
WDW3,6-DIHYDROPYRIDIN-1(2H)-YL(5-METHYL-1H-INDOL-2-YL) METHANONE4wdwAH117
NAPNADP ZWITTERION4wdxAH117
NAPNADP ZWITTERION4wdxBH117
NAPNADP ZWITTERION4xveAH117
NAPNADP ZWITTERION4yvvAH117
NAPNADP ZWITTERION4yvvBH117
NAPNADP ZWITTERION4yvxAH117
NAPNADP ZWITTERION4yvxBH117
0HV3-[(4-NITRONAPHTHALEN-1-YL)AMINO]BENZOIC ACID4dbsBH117 L128 W227
PG2PROSTAGLANDIN D21ry0AH117 L128 W227 Y319
RUTRUTIN1ry8AH117 W227
IMNINDOMETHACIN1s2aAH117 W227
FLFFLUFENAMIC ACID1s2cAH117 W227
ID8MEFENAMIC ACID3r43AH117 W227
JMSMECLOFENAMATE3r6iAH117 W227
SUZSULINDAC3r7mAH117 W227
IMNINDOMETHACIN3ugrAH117 W227
VJJ3-PHENOXYBENZOIC ACID3uweAH117 W227
0HV3-[(4-NITRONAPHTHALEN-1-YL)AMINO]BENZOIC ACID4dbsAH117 W227
BT93-{[4-(TRIFLUOROMETHYL)PHENYL]AMINO}BENZOIC ACID4dbuAH117 W227
0SZ3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YLSULFONYL)BENZOIC ACID4famAH117 W227
0SZ3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YLSULFONYL)BENZOIC ACID4famBH117 W227
WDT2-NITRO-5-(PHENYLSULFONYL)PHENOL4wdtAH117 W227
WDW3,6-DIHYDROPYRIDIN-1(2H)-YL(5-METHYL-1H-INDOL-2-YL) METHANONE4wdwBH117 W227
WDX[4-(2-HYDROXYETHYL)PIPERIDIN-1-YL](5-METHYL-1H-INDOL-2- YL)METHANONE4wdxAH117 W227
WDX[4-(2-HYDROXYETHYL)PIPERIDIN-1-YL](5-METHYL-1H-INDOL-2- YL)METHANONE4wdxBH117 W227
GBMGLIBENCLAMIDE5-CHLORO-N-(2-{4-[(CYCLOHEXYLCARBAMOYL) SULFAMOYL]PHENYL}ETHYL)-2-METHOXYBENZAMIDE4yvvAH117 W227
GBMGLIBENCLAMIDE5-CHLORO-N-(2-{4-[(CYCLOHEXYLCARBAMOYL) SULFAMOYL]PHENYL}ETHYL)-2-METHOXYBENZAMIDE4yvvBH117 W227
GMRGLIMEPIRIDE3-ETHYL-4-METHYL-N-[2-(4-{[(CIS-4-METHYLCYCLOHEXYL) CARBAMOYL]SULFAMOYL}PHENYL)ETHYL]-2-OXO-2,5-DIHYDRO- 1H-PYRROLE-1-CARBOXAMIDE4yvxAH117 W227
GMRGLIMEPIRIDE3-ETHYL-4-METHYL-N-[2-(4-{[(CIS-4-METHYLCYCLOHEXYL) CARBAMOYL]SULFAMOYL}PHENYL)ETHYL]-2-OXO-2,5-DIHYDRO- 1H-PYRROLE-1-CARBOXAMIDE4yvxBH117 W227
GCZGLICLAZIDEN-[(3AR,6AS)-HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)- YLCARBAMOYL]-4-METHYLBENZENESULFONAMIDE4zfcAH117 W227
GCZGLICLAZIDEN-[(3AR,6AS)-HEXAHYDROCYCLOPENTA[C]PYRROL-2(1H)- YLCARBAMOYL]-4-METHYLBENZENESULFONAMIDE4zfcBH117 W227
RUTRUTIN1ry8BH117 W227 H304 Y319
PG2PROSTAGLANDIN D21ry0BH117 W227 Y317 Y319
ZOMZOMEPIRAC3r8hAH117 W227 Y317 Y319
0T03-(3,4-DIHYDROISOQUINOLIN-2(1H)-YLSULFONYL)-N- METHYLBENZAMIDE4falAH117 W227 Y317 Y319
WDV4-NITRO-2-({4-[3-(TRIFLUOROMETHYL)PHENYL]PIPERAZIN-1- YL}METHYL)PHENOL4xvdAH117 W227 Y317 Y319
WDV4-NITRO-2-({4-[3-(TRIFLUOROMETHYL)PHENYL]PIPERAZIN-1- YL}METHYL)PHENOL4xvdBH117 W227 Y317 Y319
FLRR-FORM3r94AH117 W227 Y319
NPX(R) -NAPROXEN SODIUM SALT3ufyAH117 W227 Y319
0HV3-[(4-NITRONAPHTHALEN-1-YL)AMINO]BENZOIC ACID4dbsAH117 W227 Y319
0HV3-[(4-NITRONAPHTHALEN-1-YL)AMINO]BENZOIC ACID4dbsBH117 W227 Y319
BT93-{[4-(TRIFLUOROMETHYL)PHENYL]AMINO}BENZOIC ACID4dbuBH117 W227 Y319
5112'-DESMETHYL-INDOMETHACIN[1-(4-CHLOROBENZOYL)-5-METHOXY-1H-INDOL-3-YL]ACETIC ACID4dbwAH117 W227 Y319
5112'-DESMETHYL-INDOMETHACIN[1-(4-CHLOROBENZOYL)-5-METHOXY-1H-INDOL-3-YL]ACETIC ACID4dbwBH117 W227 Y319
0SL(3R)-1-(NAPHTHALEN-2-YLSULFONYL)PIPERIDINE-3-CARBOXYLIC ACID4fa3AH117 W227 Y319
16J[4-(4-CHLOROPHENYL)PIPERAZIN-1-YL](MORPHOLIN-4-YL) METHANONE4hmnAH117 W227 Y319
WDU4-CHLORO-N-(4-CHLOROBENZYL)-5-NITRO-1H-PYRAZOLE-3- CARBOXAMIDE4wduAH117 W227 Y319
IMNINDOMETHACIN3ug8AH117 Y317 Y319
NPSNAPROXEN3r58AH117 Y319
NAPNADP ZWITTERION1ry0AK84 H117
NAPNADP ZWITTERION1ry0BK84 H117
NDPNADPH1ry8AK84 H117
NAPNADP ZWITTERION3r58AK84 H117
NAPNADP ZWITTERION3r8gAK84 H117
NAPNADP ZWITTERION3ufyAK84 H117
NAPNADP ZWITTERION4dbsBK84 H117
NAPNADP ZWITTERION4dbuBK84 H117
NAPNADP ZWITTERION4wdwAK84 H117
NAPNADP ZWITTERION4wdwBK84 H117
NAPNADP ZWITTERION4xvdAK84 H117
NAPNADP ZWITTERION4xvdBK84 H117
NAPNADP ZWITTERION4zfcAK84 H117
NAPNADP ZWITTERION4zfcBK84 H117
5112'-DESMETHYL-INDOMETHACIN[1-(4-CHLOROBENZOYL)-5-METHOXY-1H-INDOL-3-YL]ACETIC ACID4dbwBL128 W227
5112'-DESMETHYL-INDOMETHACIN[1-(4-CHLOROBENZOYL)-5-METHOXY-1H-INDOL-3-YL]ACETIC ACID4dbwAW227
E043-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN1zq5AW227 Y317 Y319
10H1-(4-{[(2R)-2-METHYLPIPERIDIN-1-YL]SULFONYL}PHENYL)-1, 3-DIHYDRO-2H-PYRROL-2-ONE4h7cAW227 Y317 Y319
WDS3-PENTYL-2-[(PYRIDIN-2-YLMETHYL)SULFANYL]-7- (PYRROLIDIN-1-YLCARBONYL)QUINAZOLIN-4(3H)-ONE4xveAW227 Y317 Y319
ASDANDROST-4-ENE-3,17-DIONE1xf0AW227 Y319
15MBIMATOPROST2f38AW227 Y319
P6GHEXAETHYLENE GLYCOL2fgbAW227 Y319


Top
Conservation information for LBS of AKR1C3
Multiple alignments for P42330 in multiple species
LBSAA sequence# speciesSpecies
A218LVAYGALGTQR2Mus musculus, Rattus norvegicus
A218LVAYSALGSQR1Homo sapiens
A253YKRTPALIALR2Mus musculus, Rattus norvegicus
A253HKRTPALIALR1Homo sapiens
A269GVVVLAKSYNE1Homo sapiens
A269GIVALAKSFNE1Mus musculus
A269GIVTLVKSFNE1Rattus norvegicus
C7DSKHQCVKLND1Homo sapiens
C7NSKIQKIELND1Mus musculus
C7NSKIQKMELND1Rattus norvegicus
D224LGTQRYKYCIN2Mus musculus, Rattus norvegicus
D224LGSQRDKRWVD1Homo sapiens
D50GFRHIDSAHLY1Homo sapiens
D50GFCHIDCSHLY1Mus musculus
D50GFRHIDCSHLY1Rattus norvegicus
E192VCNQVECHLYL2Mus musculus, Rattus norvegicus
E192VCNQVECHPYF1Homo sapiens
F15LNDGHSIPVLG2Mus musculus, Rattus norvegicus
F15LNDGHFMPVLG1Homo sapiens
F284QNVQVFEFQLT1Homo sapiens
F284ENMQVFDFQLA1Mus musculus
F284ENLQVFDFQLA1Rattus norvegicus
F306RNLHYFNSDSF1Homo sapiens
F306RNLRYFPADMF1Mus musculus
F306RNLRYFPANMF1Rattus norvegicus
F311FNSDSFASHPN1Homo sapiens
F311FPADMFKAHPN1Mus musculus
F311FPANMFKAHPN1Rattus norvegicus
G22PVLGFGTYATE2Mus musculus, Rattus norvegicus
G22PVLGFGTYAPP1Homo sapiens
G220AYGALGTQRYK2Mus musculus, Rattus norvegicus
G220AYSALGSQRDK1Homo sapiens
G264YQLQRGVVVLA1Homo sapiens
G264YQLDRGIVALA1Mus musculus
G264YQLERGIVTLV1Rattus norvegicus
H117DLYLIHFPVSL2Mus musculus, Rattus norvegicus
H117DLYLIHSPMSL1Homo sapiens
H304LDRNLHYFNSD1Homo sapiens
H304LDRNLRYFPAD1Mus musculus
H304LDRNLRYFPAN1Rattus norvegicus
K270VVVLAKSYNEQ1Homo sapiens
K270IVALAKSFNEE1Mus musculus
K270IVTLVKSFNEE1Rattus norvegicus
K84IFYTSKLWSTS2Mus musculus, Rattus norvegicus
K84IFYTSKLWSTF1Homo sapiens
L122HSPMSLKPGEE1Homo sapiens
L122HFPVSLKPGNE1Mus musculus
L122HFPVSLKPGDE1Rattus norvegicus
L128KPGEELSPTDE1Homo sapiens
L128KPGNELLPKDE1Mus musculus
L128KPGDELLPQDE1Rattus norvegicus
L219VAYGALGTQRY2Mus musculus, Rattus norvegicus
L219VAYSALGSQRD1Homo sapiens
L236NSPVLLEDPVL1Homo sapiens
L236DTPVLLDDPVL1Mus musculus
L236DTPVLLDDPIL1Rattus norvegicus
L261ALRYQLQRGVV1Homo sapiens
L261ALRYQLDRGIV1Mus musculus
L261ALRYQLERGIV1Rattus norvegicus
L268RGVVVLAKSYN1Homo sapiens
L268RGIVALAKSFN1Mus musculus
L268RGIVTLVKSFN1Rattus norvegicus
L54IDCSHLYQNEE2Mus musculus, Rattus norvegicus
L54IDSAHLYNNEE1Homo sapiens
M120LIHFPVSLKPG2Mus musculus, Rattus norvegicus
M120LIHSPMSLKPG1Homo sapiens
N167SIGVSNFNRRQ3Homo sapiens, Mus musculus, Rattus norvegicus
N273LAKSYNEQRIR1Homo sapiens
N273LAKSFNEERIR1Mus musculus
N273LVKSFNEERIR1Rattus norvegicus
N280QRIRQNVQVFE1Homo sapiens
N280ERIRENMQVFD1Mus musculus
N280ERIRENLQVFD1Rattus norvegicus
N307NLHYFNSDSFA1Homo sapiens
N307NLRYFPADMFK1Mus musculus
N307NLRYFPANMFK1Rattus norvegicus
P318SHPNYPYSDEY1Homo sapiens
P318AHPNFPFFDEY1Mus musculus
P318AHPNFPFSDEY1Rattus norvegicus
Q190KPVCNQVECHP1Homo sapiens
Q190KPVCNQVECHL1Mus musculus
Q190RPVCNQVECHL1Rattus norvegicus
Q222GALGTQRYKYC2Mus musculus, Rattus norvegicus
Q222SALGSQRDKRW1Homo sapiens
Q279EQRIRQNVQVF1Homo sapiens
Q279EERIRENMQVF1Mus musculus
Q279EERIRENLQVF1Rattus norvegicus
Q6MDSKHQCVKLN1Homo sapiens
Q6MNSKIQKIELN1Mus musculus
Q6MNSKIQKMELN1Rattus norvegicus
R226TQRYKYCINED2Mus musculus, Rattus norvegicus
R226SQRDKRWVDPN1Homo sapiens
R276SYNEQRIRQNV1Homo sapiens
R276SFNEERIRENM1Mus musculus
R276SFNEERIRENL1Rattus norvegicus
S118LYLIHFPVSLK2Mus musculus, Rattus norvegicus
S118LYLIHSPMSLK1Homo sapiens
S129PGEELSPTDEN1Homo sapiens
S129PGNELLPKDEH1Mus musculus
S129PGDELLPQDEH1Rattus norvegicus
S166KSIGVSNFNRR3Homo sapiens, Mus musculus, Rattus norvegicus
S217VLVAYGALGTQ2Mus musculus, Rattus norvegicus
S217VLVAYSALGSQ1Homo sapiens
S221YGALGTQRYKY2Mus musculus, Rattus norvegicus
S221YSALGSQRDKR1Homo sapiens
S271VVLAKSYNEQR1Homo sapiens
S271VALAKSFNEER1Mus musculus
S271VTLVKSFNEER1Rattus norvegicus
S33Homo sapiens, Mus musculus, Rattus norvegicus
S308LHYFNSDSFAS1Homo sapiens
S308LRYFPADMFKA1Mus musculus
S308LRYFPANMFKA1Rattus norvegicus
S310YFNSDSFASHP1Homo sapiens
S310YFPADMFKAHP1Mus musculus
S310YFPANMFKAHP1Rattus norvegicus
T23VLGFGTYATEE2Mus musculus, Rattus norvegicus
T23VLGFGTYAPPE1Homo sapiens
V137DENGKVIFDIV1Homo sapiens
V137DEHGNLIFDTV1Mus musculus
V137DEHGNLILDTV1Rattus norvegicus
V18GHSIPVLGFGT2Mus musculus, Rattus norvegicus
V18GHFMPVLGFGT1Homo sapiens
V265QLQRGVVVLAK1Homo sapiens
V265QLDRGIVALAK1Mus musculus
V265QLERGIVTLVK1Rattus norvegicus
V8SKHQCVKLNDG1Homo sapiens
V8SKIQKIELNDG1Mus musculus
V8SKIQKMELNDG1Rattus norvegicus
W227QRYKYCINEDT2Mus musculus, Rattus norvegicus
W227QRDKRWVDPNS1Homo sapiens
W86YTSKLWSTSHR2Mus musculus, Rattus norvegicus
W86YTSKLWSTFHR1Homo sapiens
Y216IVLVAYGALGT2Mus musculus, Rattus norvegicus
Y216IVLVAYSALGS1Homo sapiens
Y24LGFGTYAPPEV1Homo sapiens
Y24LGFGTYATEEH1Mus musculus
Y24LGFGTYATEEN1Rattus norvegicus
Y272VLAKSYNEQRI1Homo sapiens
Y272ALAKSFNEERI1Mus musculus
Y272TLVKSFNEERI1Rattus norvegicus
Y305DRNLHYFNSDS1Homo sapiens
Y305DRNLRYFPADM1Mus musculus
Y305DRNLRYFPANM1Rattus norvegicus
Y317ASHPNYPYSDE1Homo sapiens
Y317KAHPNFPFFDE1Mus musculus
Y317KAHPNFPFSDE1Rattus norvegicus
Y319HPNYPYSDEY1Homo sapiens
Y319HPNFPFFDEY1Mus musculus
Y319HPNFPFSDEY1Rattus norvegicus
Y55DCSHLYQNEEE2Mus musculus, Rattus norvegicus
Y55DSAHLYNNEEQ1Homo sapiens


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas